The First Hospital of Jilin University
π¨π³China
- Country
- π¨π³China
- Ownership
- -
- Established
- 1920-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.bethune-jilin.cn
Cadonilimab Monotherapy as Neoadjuvant Therapy for Resectable II-IIIA Squamous Cell Lung Cancer
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2023-03-27
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 37
- Registration Number
- NCT05784974
Predictive Value of PS Application in Premature Infants With RDS
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-03-16
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 1392
- Registration Number
- NCT05772247
Neutrophil Elastase Inhibitor in Treatment of ARDS Patients With Mechanical Ventilation Caused by Sepsis
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-01-05
- Last Posted Date
- 2023-01-05
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 100
- Registration Number
- NCT05672472
Remote Ischemic Conditioning and Dynamic Cerebral Autoregulation in Patients With Intracranial and Extracranial Arteriosclerosis
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-31
- Last Posted Date
- 2023-02-14
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 140
- Registration Number
- NCT05599009
- Locations
- π¨π³
First Hospital of Jilin University, Changchun, Jilin, China
Transabdominal Gastric Contrast Ultrasound
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2022-10-27
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 1000
- Registration Number
- NCT05596864
Comparison of Analgesic and Sedative Effects of Esmketamine and Remifentanil Combined With Propofol Respectively in Septic Shock Patients With Invasive Mechanical Ventilation
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2022-09-23
- Last Posted Date
- 2022-09-23
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 120
- Registration Number
- NCT05551910
Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma
- First Posted Date
- 2022-08-22
- Last Posted Date
- 2022-09-10
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 46
- Registration Number
- NCT05509478
- Locations
- π¨π³
Liu Bo, Changchun, Jilin, China
Clinical Analysis of Juvenile Dermatomyositis Patients
Completed
- Conditions
- First Posted Date
- 2022-08-19
- Last Posted Date
- 2022-08-19
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 12
- Registration Number
- NCT05509140
A Prospective, Single Center Clinical Study of Toripalimab Combined With FLOT Regimen for Perioperative Treatment of PD-L1 Positive Locally Advanced Resectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma (GEJ)
Phase 2
Recruiting
- Conditions
- First Posted Date
- 2022-07-20
- Last Posted Date
- 2022-07-20
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 30
- Registration Number
- NCT05466019
- Locations
- π¨π³
First Hospital of Jilin University, Changchun, Ji Lin, China
Stoma Discharge Reinfusion After Sphincter Preservation for Middle and Low Rectal Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2024-11-22
- Lead Sponsor
- The First Hospital of Jilin University
- Target Recruit Count
- 60
- Registration Number
- NCT05461248
- Locations
- π¨π³
Jilin University First Hospital, Changchun, Jilin, China
Β© Copyright 2024. All Rights Reserved by MedPath